Press Releases

Optical Brighteners, Plasticizers, and Antioxidants as Polymer Stabilizers

Biopharma PEG To Attend PEGS Boston Summit 2023

Huateng Pharma Announced To Present CPhI North America In April 2023

Curebase Selected Among Y Combinator’s Top Private Companies of 2023

DCT platform company places in top 6% of private companies; recognized for end-to-end clinical trial execution built on cutting-edge software

CD ComputaBio Introduces AutoDock, a Powerful Molecular Docking Software

TransCure bioServices delivers CDX mouse models to advance AML preclinical studies

TransCure bioServices has developed cell line-derived xenograft (CDX) mouse models that will change how researchers tackle the preclinical studies of cancer therapies to treat acute myeloid leukemia (AML).

Creative Enzymes Releases Restriction Enzymes for Molecular Biology Research

Alfa Chemistry to Present at the Upcoming ACS Spring 2023 Conference

Alfa Chemistry, a chemical company focused on supplying high-quality chemicals and materials for both academia and the industry, today announced that members of its Senior Management Team are scheduled to participate in the upcoming ACS Spring 2023 Conference in March at Indiana Convention Center, located in 100 S Capitol Ave, Indianapolis, IN 46225.

Alfa Chemistry Announces to Participate in the Upcoming Pittcon Conference & Exposition 2023

The New York-based chemical vendor Alfa Chemistry recently announced its attendance at the upcoming Pittcon Conference & Exposition 2023. This five-day event will take place at Pennsylvania Convention Center from 18th – 22nd March 2023.

Creative Proteomics Enhances Your Project with Cell Surface Proteomics Service

Creative Proteomics Cytokine Boosts Cancer Research with Cancer Cytokines Assay

Pronalyse Announces the Launch of Epitope Mapping Service Utilizing HDX-MS Technology

CD Formulation Upgrades Its Database of Pharmaceutical Excipients, Cosmetic Ingredients, and Food Ingredients

Chiral Derivatization Reagents, Cosmetic Additives, and Organic Field Effect Transistor Materials

Jumo Health Launches Suite of Services to Drive Health Equity in Clinical Trials

Expanded offerings will increase Black representation in clinical trials, ensuring that new medicines are safe and effective for people of color.

IntegrateRNA Offer Custom Production of Peptide-oligonucleotide Conjugates (POC) to Optimize Therapeutic Research

Microbiosci Offers Yeast Cell Bank Characterization Service to Value Microbial Cell Banks

Creative Biogene Develops High-performance CHO Stable Cell Line Development Platform

Cerba Research and Teddy Lab sign Memorandum of Understanding on entering into a discussion for Joint Venture

Cerba Research has announced a Memorandum of Understanding (MoU) with Teddy Clinical Research Laboratory to lay the foundation for an in-depth discussion towards the creation of a Joint Venture (JV).

SERDA therapeutics submits IND for its lead product, an innovative wound debridement agent

SERDA therapeutics has submitted an Investigational New Drug Application (IND) to the US FDA on the 17th February for its lead product SN514 hydrogel, an innovative enzymatic wound debriding agent. Clinical studies are expected to start in Q2 2023.